Michael Barbella, Managing Editor09.23.23
Diabetes innovation took the top prize on MPO's website this past week.
Readers overwhelmingly favored news of an MIT-designed implantable device that not only carries hundreds of thousands of insulin-producing islet cells, but also has its own on-board oxygen factory, which generates oxygen by splitting water vapor found in the body. Researchers showed that when implanted into diabetic mice, this device could keep the mice’s blood glucose levels stable for at least a month. Scientists now hope to create a larger version of the device that could eventually be tested in people with Type 1 diabetes.
Trailing MIT's creating (pageview-wise) was two features from the magazine's September issue—an in-depth look at medtech assembly/automation trends, and a discussion on design changes within the scope of the EU's new Medical Device Regulation.
GE Healthcare and Thermo Fisher Scientific also drove considerable traffic this week with product and personnel news, respectively. GE HealthCare enticed cybervisitors with word of a more than $44 million Bill & Melinda Gates Foundation grant for building user-friendly, artificial intelligence (AI)-assisted ultrasound imaging auto-assessment tools. The tools would aim to help healthcare professionals, even those without specialized ultrasound training or experience, with clinical decision information to support more effective obstetric and lung screening ultrasounds in maternal care, fetal care, and pediatric lung health.
Thermo Fisher, meanwhile, gained notice for electing Franklin Resources CEO Jenny Johnson to its board.
Readers overwhelmingly favored news of an MIT-designed implantable device that not only carries hundreds of thousands of insulin-producing islet cells, but also has its own on-board oxygen factory, which generates oxygen by splitting water vapor found in the body. Researchers showed that when implanted into diabetic mice, this device could keep the mice’s blood glucose levels stable for at least a month. Scientists now hope to create a larger version of the device that could eventually be tested in people with Type 1 diabetes.
Trailing MIT's creating (pageview-wise) was two features from the magazine's September issue—an in-depth look at medtech assembly/automation trends, and a discussion on design changes within the scope of the EU's new Medical Device Regulation.
GE Healthcare and Thermo Fisher Scientific also drove considerable traffic this week with product and personnel news, respectively. GE HealthCare enticed cybervisitors with word of a more than $44 million Bill & Melinda Gates Foundation grant for building user-friendly, artificial intelligence (AI)-assisted ultrasound imaging auto-assessment tools. The tools would aim to help healthcare professionals, even those without specialized ultrasound training or experience, with clinical decision information to support more effective obstetric and lung screening ultrasounds in maternal care, fetal care, and pediatric lung health.
Thermo Fisher, meanwhile, gained notice for electing Franklin Resources CEO Jenny Johnson to its board.